🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the present multicentre, prospective, non-interven...
Status
Completed
Location
Beijing children's Hospital, Capital Medical University
Start Date
2021-03-18
Trial ID
NCT04976868
Treatments Being Tested
To establish the bioequivalence between test drug, Pimecrolimus Cream, 1% w...
Status
Completed
Location
Research Facility 6
Start Date
2016-02-29
Trial ID
NCT03107611
Treatments Being Tested
This is an investigator-blinded, bilateral comparison study in 30 subjects ...
Status
Completed
Location
Mount Sinai Faculty Practice Associates
Start Date
2010-03
Trial ID
NCT01202149
Treatments Being Tested
A phase 3, double-blind, randomized, parallel-group, placebo-controlled, mu...
Status
Completed
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT03297502
Treatments Being Tested
This study consists of a 3-year double-blind phase during which patients wi...
Status
Terminated
Location
Alabama Allergy and Asthma Center
Start Date
2003-10
Trial ID
NCT00124709
Treatments Being Tested
Lichen sclerosus (LS) is a skin condition of the external genitals (vulva) ...
Status
Completed
Location
Center for VulvoVaginal Disorders
Start Date
2006-10
Trial ID
NCT00393263
Treatments Being Tested
This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Mul...
Status
Completed
Location
Investigational Site 4
Start Date
2016-08
Trial ID
NCT02896101
Treatments Being Tested
This study investigated whether initiation of everolimus together with redu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2005-12
Trial ID
NCT00377962
Treatments Being Tested
Elidel® is indicated for the short-term treatment and long-term management ...
Status
Active Not Recruiting
Location
Viatris Clinical Site
Start Date
2024-10-15
Trial ID
NCT06052995
Treatments Being Tested